Observations placeholder

Sotalol

Sotalol is a drug used in individuals with rhythm disturbances (cardiac arrhythmias) of the heart, and to treat hypertension in some individuals. It is a non-selective competitive β-adrenergic receptor blocker that also exhibits Class III antiarrhythmic properties by its inhibition of potassium channels.^] Because of this dual action, Sotalol prolongs both the PR interval and the QT interval. Originally discovered around 1960, sotalol became widely used first as a β-blocker in the 1980s, and its function as an antiarrhythmic drug was discovered soon after.  Due to the dual action of sotalol, it is often used preferentially to other β-blockers as treatment for both ventricular fibrillation and ventricular tachycardia.

Trade names for Sotalol include Betapace and Betapace AF , and Sotalex and Sotacor

On Mar, 11, 2015: 1,932 people reported to have side effects when taking Sotalol hydrochloride. Among them, 8 people (0.41%) have Hallucination.

On Mar, 12, 2015: 1,932 people reported to have side effects when taking Sotalol hydrochloride. Among them, 23 people (1.19%) have Death.